TITLE

Comparison of GnRH agonists and antagonists in the outcome of IVF/ICSI in women with polycystic ovary syndrome

AUTHOR(S)
Zeinalzadeh, M.; Norani, N.; Esmaeilzadeh, S.; Yousefniapasha, Y.; Firoozpour, M.; Khafri, S.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: To compare the outcome of using gonadotropin-releasing hormone (GnRH) antagonists versus agonists in women with polycystic ovary syndrome (PCOS) who underwent controlled ovarian hyper stimulation (COH) for assisted reproductive techniques (ART). Materials and Methods: A total of 120 patients with PCOS were randomly allocated to undergo COH with a GnRH antagonist (Buserelin) (60 patients) and GnRH agonist (Cetrorelix) (60 patients).The primary Outcome measure was pregnancy occurrence. Basal characteristics of the participants, stimulation cycle responses, pregnancy outcomes and incidence of OHSS were considered in both groups. Results: The mean age and the mean of duration infertility of all patients was 28.6±4.4, 5.8±4 respectively. There was no significant difference between the antagonist and agonist arms in the Pregnancy rates, duration of ovarian stimulation, numbers of retrieved oocyte and fertilization rates. Number of gonadotropin ampoules consumed per cycle and incidence of ovarian hyper stimulation syndrome (OHSS) was significantly lower in the antagonist group. Conclusion: It seems because of not significant difference in pregnancy rate between two treatment protocols and positive effect of antagonist in consumed gonadotropin ampoules and OHSS incidence, GnRH Antagonist is more preferable for PCOS women.
ACCESSION #
96841620

 

Related Articles

  • ART, clinical: GnRH agonist/antagonist.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi120 

    The article presents abstracts on the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists in assisted reproductive technology (ART), including the administration of gonadoliberine analogues (GnRH-a) to patients with Hodgkin lymphoma (HL) during chemotherapy and prevention of...

  • Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist. Kumbak, Banu; Akbas, Hande; Sahin, Levent; Karlikaya, Guvenc; Karagozoglu, Hale; Kahraman, Semra // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2010, Vol. 20 Issue 3, p314 

    This study evaluated women with a high body mass index (BMI) (>40 kg/m²) and low BMI (<18 kg/m²) undergoing assisted reproduction treatment and determined whether the type of gonadotrophin-releasing hormone (GnRH) analogue used has an impact on cycle parameters and outcome. The study...

  • GnRH Antagonist Produces Similar Results as GnRH-Agonist.  // Fertility Weekly;12/6/2010, p8 

    The article presents a study which aims to determine the effectiveness of luteinizing hormone releasing hormone (GnRH) antagonist and luteinizing hormone releasing hormone (GnRH) agonist protocol in polycystic ovary syndrome (PCOS) patients pretreated with oral contraceptive pill (OCP)....

  • Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Orvieto, Raoul; Nahum, Ravit; Meltcer, Simion; Homburg, Roy; Rabinson, Jacob; Anteby, Eyal Y.; Ashkenazi, Jacob // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2009, Vol. 18 Issue 3, p333 

    In an attempt to examine whether body mass index (BMI) may influence IVF outcome in polycystic ovary syndrome (PCOS) patients undergoing ovarian stimulation with either gonadotrophin-releasing hormone (GnRH)-agonist (agonist group) or antagonist (antagonist group), 100 IVF cycles were studied:...

  • Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Vrtačnik-Bokal, Eda; Klun, Irma Virant; Verdenik, Ivan // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan2009, Vol. 18 Issue 1, p21 

    The aim of this study was to determine whether follicular oestradiol and vascular endothelial growth factor (VEGF) concentrations in women with polycystic ovarian syndrome (PCOS) differ according to the use of gonadotrophin-releasing hormone (GnRH) antagonists or GnRH agonists. Furthermore, the...

  • GnRH Combined with Luteal Phase Estradiol Comparable to GnRH.  // Fertility Weekly;11/12/2007, p8 

    The article reports on the results of a study conducted in Brazil that addressed the efficacy of combining luteinizing hormone releasing hormone (GnRH) with luteal phase estradiol for ovarian stimulation. The study inhibited a precocious liberation of the luteinizing hormone (LH) by the...

  • GnRH AGONIST AND ANTAGONIST: HOW TO OPTIMIZE THEIR USE IN OVARIAN STIMULATION. Leondires, M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2010 Supplement 1, Vol. 21 Issue S1, pS9 

    An abstract of the lecture "GnRH Agonist and Antagonist: How to Optimize Their Use in Ovarian Stimulation" by M. Leondires is presented.

  • Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Tarlatzis, B. C.; Kolibianakis, E. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p8 

    The wide application of gonadotrophin-releasing hormone (GnRH) analogues in assisted reproduction has raised concerns about their potential extra-pituitary actions. Although data from animal studies support the presence of ovarian GnRH receptors and of direct ovarian effects of GnRH analogues,...

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics